Recent News

• 08.18.2025 - Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
• 08.18.2025 - Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
• 08.14.2025 - Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
• 08.14.2025 - Traws Pharma Reports Second Quarter 2025 Results and Business Highlights
• 08.08.2025 - Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
• 08.08.2025 - Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
• 06.30.2025 - Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
• 06.30.2025 - Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions

Recent Filings

• 08.18.2025 - EX-99.1 EX-99.1
• 08.18.2025 - 8-K Current report
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - 8-K Current report
• 07.03.2025 - 8-K Current report
• 06.30.2025 - 8-K Current report
• 06.30.2025 - EX-99.1 EX-99.1
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.23.2025 - 4 Statement of changes in beneficial ownership of securities